5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzonitrile, 96%, 100mg

2-Fluoro-5-pyridine carboxylic acid, 90.0%, 1g

3,5-Dichlorobenzenesulfonamide, 97.0%, 5g

3,6-Dibromo-2,7-diiodophenanthrene-9,10-dione, 95%, 5g

tert-Butyl 2-iodoacetate, 95.0%, 5g

Sodium 2-aminonaphthalene-1-sulfonate, 95+%, 5g

(R)-1-N-Boc-3-Cyanopiperazine, 95.0%, 1g

Ethyl 2-butynoate, 98.0%, 10g

2-Benzyl-5-iodopyridazin-3(2H)-one, 95.0%, 250mg

Ixazomib citrate, 98%, 250mg

1,5-Dibromo-2-iodo-4-methoxybenzene, 98%, 5g

[3-cyclopropyl-4-(difluoromethyl)-6-(1-ethyl-5-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]acetic acid, 95.0%, 1g

N-Fmoc-N-(2-phenylethyl)-glycine, 97%, 250mg